AIKI
insider transactionsAikido Pharma Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $371.5K.
Net shares · 365d
-183.4K
96.0K buy · 279.4K sell
Net value · 365d
-$673.7K
$371.5K in · $1.0M out
Sentiment · 365d
Net selling
26% buying · 74% selling
Open-market trades · 365d
9
96.0K buy · 279.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
President
—
3.0M sh
Own +248%
-
Grant·A
Hayes Anthony KEY
CEO
—
3.0M sh
Own +171%
-
Grant·A
Director
—
25.0K sh
Own +112%
-
Grant·A
Director
—
25.0K sh
Own +102%
-
Grant·A
Director
—
25.0K sh
Own New
-
Grant·A
LEDWICK TIM S KEY
Chief Financial Officer
—
316.3K sh
Own +1005%
-
Grant·A
—
10.0K sh
Own +7%
-
Buy·P
President
$96.8K
25.0K sh · $3.87
Own +2%
-
Buy·P
President
$96.8K
25.0K sh · $3.87
Own +1%
-
Buy·P
Hayes Anthony KEY
CEO
$89.0K
23.0K sh · $3.87
Own +1%
-
Buy·P
Hayes Anthony KEY
CEO
$89.0K
23.0K sh · $3.87
Own +1%
-
Sell·S
$173.2K
45.0K sh · $3.85
Own -24%
-
Sell·S
$534.8K
140.0K sh · $3.82
Own -42%
-
Sell·S
$168.4K
40.0K sh · $4.21
Own -11%
-
Sell·S
$168.8K
40.0K sh · $4.22
Own -10%
-
Sell·S
Director
—
14.4K sh
Own -39%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Wool Kyle Michael KEY | Grant A | 3.0M | — |
| Mar 4, 2026 | Hayes Anthony KEY | Grant A | 3.0M | — |
| Jan 9, 2026 | Blattner Gregory James | Grant A | 25.0K | — |
| Jan 9, 2026 | Haug Kyle | Grant A | 25.0K | — |
| Jan 9, 2026 | Parsley Brian Keith | Grant A | 25.0K | — |
| Jan 9, 2026 | LEDWICK TIM S KEY | Grant A | 316.3K | — |
| Dec 11, 2025 | Devall Christopher Franklin | Grant A | 10.0K | — |
| Dec 8, 2025 | Wool Kyle Michael KEY | Buy P | 25.0K | $96.8K |
| Dec 8, 2025 | Wool Kyle Michael KEY | Buy P | 25.0K | $96.8K |
| Dec 8, 2025 | Hayes Anthony KEY | Buy P | 23.0K | $89.0K |
| Dec 8, 2025 | Hayes Anthony KEY | Buy P | 23.0K | $89.0K |
| Dec 8, 2025 | Devall Christopher Franklin | Sell S | 45.0K | $173.2K |
| Dec 5, 2025 | Devall Christopher Franklin | Sell S | 140.0K | $534.8K |
| Dec 4, 2025 | Devall Christopher Franklin | Sell S | 40.0K | $168.4K |
| Dec 3, 2025 | Devall Christopher Franklin | Sell S | 40.0K | $168.8K |
| Sep 23, 2025 | Blattner Gregory James | Sell S | 14.4K | — |
About AIKI insider trading
This page tracks insider transactions for Aikido Pharma Inc. (AIKI) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.